Class summary at a glance.

Every drug in the Vitamin K Antagonist (Anticoagulant) class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $68.3Mcombined across class
Total Rx claims: 7.4M1.7M unique beneficiaries
Generic mfrs (active): 6across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Warfarin

Brand: Jantoven · 7.4M Part D claims (CY24) · 1.7M beneficiaries · First FDA approval: 1999-07-15

6 generic mfrs 0 plans require PA

Low NADAC$0.079

→

Avg plan cost$0.087

Part D spend $68.3M 1× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.